Skip to main content
AkademIndex

Products

For developers

AkademBaseOpen API for the ecosystem

Junko Tanaka

9 works

Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan. [email protected]

  1. Seroepidemiological study of factors affecting anti-spike IgG antibody titers after a two-dose mRNA COVID-19 vaccination in 3744 healthy Japanese volunteers

    Aya Sugiyama, Akemi Kurisu, Shintaro Nagashima +13

    ArticleSARS-CoV-2 and COVID-19 ResearchScientific Reports20221 citations
    ABI

  2. Eighteen‐year follow‐up cohort study on hepatitis B and C virus infections related long‐term prognosis among hemodialysis patients in Hiroshima

    Ko Ko, Shintaro Nagashima, Chikako Yamamoto +9

    ArticleHepatitis B Virus StudiesJournal of Medical Virology20200 citations
    ABI

  3. Variant-specific Symptoms After COVID-19: A Hospital-based Study in Hiroshima

    Kanon Abe, Aya Sugiyama, Noriaki Ito +11

    ArticleLong-Term Effects of COVID-19Journal of Epidemiology20230 citations
    ABI

  4. Author Correction: Seroepidemiological study of factors affecting anti-spike IgG antibody titers after a two-dose mRNA COVID-19 vaccination in 3744 healthy Japanese volunteers

    Aya Sugiyama, Akemi Kurisu, Shintaro Nagashima +13

    OtherImmunotherapy and Immune ResponsesScientific Reports20230 citations
    ABI

  5. Development of a unit conversion tool for five quantitative anti‐spike assays and agreement analysis of three qualitative anti‐nucleocapsid assays for SARS‐CoV‐2

    Serge Ouoba, Aya Sugiyama, Ko Ko +11

    ArticleSARS-CoV-2 detection and testingJournal of Medical Virology20240 citations
    ABI

  6. Assessing the diagnostic accuracy of serological tests for hepatitis delta virus diagnosis: a systematic review and meta-analysis

    Golda Ataa Akuffo, Serge Ouoba, Ko Ko +6

    Review articleHepatitis B Virus StudiesScientific Reports20240 citations
    ABI

  7. Intermediate hepatitis C virus (HCV) endemicity and its genotype distribution in Myanmar: A systematic review and meta-analysis

    Zayar Phyo, Ko Ko, Serge Ouoba +6

    Review articleHepatitis C virus researchPLoS ONE20240 citations
    ABI

  8. Number of people treated for hepatitis C virus infection in 2014-2023 and applicable lessons for new HBV and HDV therapies

    Homie Razavi, Imam Waked, Huma Qureshi +97

    ArticleHepatitis C virus researchJournal of Hepatology20250 citations
    ABI

  9. Weighted prevalence and associated risk factors of hepatitis E virus antibodies among pregnant women in rural Burkina Faso using dried blood spot samples

    Chanroth Chhoung, Serge Ouoba, Moussa Lingani +11

    ArticleHepatitis Viruses Studies and EpidemiologyHepatology Research20250 citations
    ABI